Director Global Tax Transfer Pricing


As one of the world's leading pharmaceutical companies, this position is a highly visible, project-oriented position. This position operates as a Director, Transfer Pricing and will participate in all aspects of Global Tax's transfer pricing policy maintenance and defense. The position is based at the company's New York, NY or Peapack, NJ offices.

The candidate must be a highly motivated transfer pricing professional with proven leadership skills and understanding of the pharmaceutical industry. This role is complex requiring strong financial analysis and technical transfer pricing skills. A thorough understanding of management accounting and an ability to analyze and understand financial statements is critical. Must be familiar with international tax issues in complex intercompany and third-party transactions.

The position also requires experience with tax audit controversy in both the US and/or abroad.

Excellent oral and written communication skills are required, particularly the ability to explain complex tax strategies and concepts to non-tax professionals at very senior levels.

  • Working with Transfer Pricing Center of Excellence (TP CoE) and International Tax Counsels as Transfer Pricing Country Lead for specific assigned markets;
  • Understanding all aspects of financial and functional operations in assigned markets;
  • Handling inquiries regarding accounting and operational issues raised by the various business units, functional organizations and local markets within Pfizer;
  • Participating in all aspects of product pricing and legal entity profit reviews for assigned markets including assessing reasonableness of transfer prices for tangible goods and services by gathering all relevant facts and data;
  • Providing necessary analyses to support recommendations about intangible and tangible goods pricing;
  • Ensuring compliance with all transfer pricing requirements in assigned markets including preparation of transfer pricing documentation reports, assistance with disclosure forms etc;
  • Providing Tax Audit support on transfer pricing issues for both US and assigned foreign markets including analyzing local financials, preparing responses to IDRs, anticipating areas of potential controversy based on knowledge of the market;
  • Supporting all aspects of financial and functional analyses to determine transfer pricing implications of supply chain decisions, deals and acquisitions;
  • Analysis of intercompany service arrangements;
  • Collaborating effectively across the tax, finance, legal and operating organizations within Pfizer;
  • Managing multiple projects in a dynamic and complex environment;
  • Keeping abreast of developments in US and OECD tax/transfer pricing regulations and identifying issues or opportunities attendant to those developments;
  • Understanding the pharmaceutical industry.

  • Strong technical Transfer Pricing background with minimum of 10 years of experience, at least half of which was within a Transfer Pricing specialty practice in either a Big 4 or specialty consulting firm.
  • Bachelor's degree required. Master's degree strongly preferred, preferably in Economics, Finance (MBA) or related quantitative field.
  • CPA or experience with corporate tax reporting, a plus but not required.
  • IRS and or foreign tax audit experience strongly preferred.
  • Excellent communication skills both written and oral required.
  • Ability to work with and influence others.
  • Strong project management skills, highly motivated self-starter.
  • Understanding of the pharmaceutical or chemical industries a plus.

Candidate demonstrates a breadth of diverse leadership experiences and capabilities including: the ability to influence and collaborate with peers, develop and coach others, oversee and guide the work of other colleagues to achieve meaningful outcomes and create business impact.

Pfizer requires all U.S. new hires to be fully vaccinated for COVID-19 prior to the first date of employment. As required by applicable law, Pfizer will consider requests for Reasonable Accommodations.

Sunshine Act

Pfizer reports payments and other transfers of value to health care providers as required by federal and state transparency laws and implementing regulations. These laws and regulations require Pfizer to provide government agencies with information such as a health care provider's name, address and the type of payments or other value received, generally for public disclosure. Subject to further legal review and statutory or regulatory clarification, which Pfizer intends to pursue, reimbursement of recruiting expenses for licensed physicians may constitute a reportable transfer of value under the federal transparency law commonly known as the Sunshine Act. Therefore, if you are a licensed physician who incurs recruiting expenses as a result of interviewing with Pfizer that we pay or reimburse, your name, address and the amount of payments made currently will be reported to the government. If you have questions regarding this matter, please do not hesitate to contact your Talent Acquisition representative.

EEO & Employment Eligibility

Pfizer is committed to equal opportunity in the terms and conditions of employment for all employees and job applicants without regard to race, color, religion, sex, sexual orientation, age, gender identity or gender expression, national origin, disability or veteran status. Pfizer also complies with all applicable national, state and local laws governing nondiscrimination in employment as well as work authorization and employment eligibility verification requirements of the Immigration and Nationality Act and IRCA. Pfizer is an E-Verify employer.

Finance & Accounting